Anuva is a translational research company that is committed to creating the world's most diverse Genomic Bio/Data Bank. With a focus on uncovering novel biological pathways for drug discovery, Anuva aims to address the limited diversity found within genomic sequences for analysis, which is predominantly represented by Caucasians. By collecting genomic data from diverse populations and blending it with data on disease traits, Anuva's Genomic Bio/Data Bank empowers researchers to create new knowledge that is not possible with DNA sequence data alone.

Anuva understands the importance of diversity in unlocking the true potential of genomics and offers specialized services in collecting and interpreting genomic data. They strive to be the partner that drug discovery teams need, providing the necessary resources and expertise to facilitate groundbreaking discoveries. To further support the science community, Anuva offers valuable insights into the impact of genomics on drug discovery and development.

Their co-founder, Dr. Jonathan Picker, provides his expertise as an affiliate faculty member and clinical geneticist at Boston's Children's Hospital, Harvard Medical School. Led by a team of experienced professionals, including President Kushagra Sharma, Vice President of Data and Technology Dr.

Asmi Shah, and CEO Naveen Tewari, Anuva is dedicated to revolutionizing genomics in drug discovery and development. With their expertise and commitment to diversity, Anuva is poised to shape the future of genomics in the coming decade